RUNX1 and leukemia: However, the notion that RUNX1 is simply a suppressor whose loss of functions confers an automatic growth advantage is challenged by more recent observations that human leukemia cells bearing the common RUNX1‐ETO fusion cannot tolerate loss of the remaining wild‐type RUNX1 allele [Ben‐Ami et al., 2013].